Evaluation of Tumoral Perfusion Modification by Dynamic Imaging After Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Patients With Potentially Operable, Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms NEOPAX001
- 31 Aug 2018 Biomarkers information updated
- 07 May 2017 Status changed from recruiting to completed.
- 23 Aug 2014 Status changed from not yet recruiting to recruiting, as per European Clinical Trials Database record.